AMD macular degeneration

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\AMD macular degeneration.php on line 2
AMD macular degeneration

LE WE PMID CA

AMD macular degeneration

116

AMD Altersabhaengige Makuladegeneration

AMD macular degeneration

Anecortave acetate

Apolipoprotein B

CNS (Stroke BASKET)

Drusen

ERS UFR (Diseases)

Eye (Retina BASKET)

Eye and orbita (Neovascularization)

Pegaptanib

Phototoxicity

Ranibizumab ttVEGF

2003 1	Age related macular degeneration. [12609947] BMJ 326(7387): 485-8 (2003)
2007 2	An update of treatment options for neovascular age-related macular degeneration. [18057435] Hong Kong Med J 13(6): 460-70 (2007)
2005 3	Age-related macular degeneration. [16235759] Ulster Med J 74(2): 82-92 (2005)
2003 4	Age-related macular degeneration: evaluation and treatment. [14686682] Cleve Clin J Med 70(12): 1017-8, 1020, 1023-5 passim (2003)
2006 5	Ranibizumab in neovascular age-related macular degeneration. [18046922] Clin Interv Aging 1(4): 451-66 (2006)
2009 6	The treatment of wet age-related macular degeneration. [19547647] Dtsch Arztebl Int 106(18): 312-7 (2009)
2007 7	Age-related macular degeneration: a target for nanotechnology derived medicines. [17722514] Int J Nanomedicine 2(1): 65-77 (2007)
2006 8	Pegaptanib in the treatment of wet, age-related macular degeneration. [17717967] Int J Nanomedicine 1(3): 263-8 (2006)
2008 9	A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration. [18513468] Health Technol Assess 12(27): iii-iv, ix-124 (2008)
2008 10	Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. [18462575] Health Technol Assess 12(16): iii-iv, ix-201 (2008)
2003 11	Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. [12709292] Health Technol Assess 7(9): v-vi, 1-98 (2003)
2007 12	Molecular genetics of AMD and current animal models. [17372852] Angiogenesis 10(2): 119-32 (2007)
2009 13	The molecular genetic basis of age-related macular degeneration: an overview. [20090206] J Genet 88(4): 425-49 (2009)
1998 14	Age-related macular degeneration. [9683972] Postgrad Med J 74(870): 203-7 (1998)
2000 15	External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data. [10817048] Br J Radiol 73(867): 305-13 (2000)
2010 16	Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study. [20144224] BMC Ophthalmol 10(): 2 (2010)
2007 17	Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration. [17951899] Indian J Ophthalmol 55(6): 431-5 (2007)
2007 18	Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration. [17951895] Indian J Ophthalmol 55(6): 413-5 (2007)
2000 19	New approaches in the management of choroidal neovascular membrane in age-related macular degeneration. [11340884] Indian J Ophthalmol 48(4): 263-78 (2000)
2007 20	An update on the genetics of age-related macular degeneration. [17327825] Mol Vis 13(): 196-205 (2007)
1999 21	Pathogenesis and Treatment of Age-Related Macular Degeneration: Current Knowledge and Leads for Future Research. June 4-6, 1998. Baltimore, Maryland, USA. Proceedings. [10610222] Mol Vis 5(-): 24-35 (1999)
1999 22	Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. [10562659] Mol Vis 5(-): 35 (1999)
1999 23	The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. [10562658] Mol Vis 5(-): 34 (1999)
1983 24	Make your partnership work by adhering to a well-defined agreement. [10262657] Can Doct 49(9): 79-80 (1983)
1983 25	Are you prepared to invest in a medical office building? [10262656] Can Doct 49(9): 67-9 (1983)
1999 26	Cell death in age-related macular degeneration. [10562655] Mol Vis 5(-): 31 (1999)
1999 27	What can we learn about age-related macular degeneration from other retinal diseases? [10562654] Mol Vis 5(-): 30 (1999)
1999 28	The genetics of age-related macular degeneration. [10562653] Mol Vis 5(-): 29 (1999)
1999 29	Molecular composition of drusen as related to substructural phenotype. [10562652] Mol Vis 5(-): 28 (1999)
1999 30	Histopathology of age-related macular degeneration. [10562651] Mol Vis 5(-): 27 (1999)
1999 31	Epidemiology of age-related macular degeneration. [10562650] Mol Vis 5(-): 26 (1999)
1999 32	The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. [10562649] Mol Vis 5(-): 25 (1999)
2009 33	Treatment of neovascular age-related macular degeneration: Current therapies. [19668562] Clin Ophthalmol 3(): 175-82 (2009)
2009 34	Age-related macular degeneration: experimental and emerging treatments. [19668561] Clin Ophthalmol 3(): 167-74 (2009)
2009 35	Age-related macular degeneration: current treatments. [19668560] Clin Ophthalmol 3(): 155-66 (2009)
2008 36	Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice. [18637105] Clin Exp Optom 91(5): 427-37 (2008)
2007 37	Age-related maculopathy in the light of ischaemia. [17535365] Clin Exp Optom 90(4): 263-71 (2007)
2005 38	Treatment of age-related macular degeneration. [16255691] Clin Exp Optom 88(5): 322-34 (2005)
2005 39	Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram. [16255689] Clin Exp Optom 88(5): 304-12 (2005)
2005 40	Assessment of age-related maculopathy using subjective vision tests. [16255688] Clin Exp Optom 88(5): 292-303 (2005)
2001 41	The genetics of age-related macular degeneration. [12366313] Clin Exp Optom 84(4): 182-189 (2001)
2006 42	Lesion morphology in age-related macular degeneration and its therapeutic significance. [16769834] Arch Ophthalmol 124(6): 807-12 (2006)
2004 43	Scanning laser entoptic perimetry for the detection of age-related macular degeneration. [15534125] Arch Ophthalmol 122(11): 1647-51 (2004)
2007 44	Guidance for the treatment of neovascular age-related macular degeneration. [17655610] Acta Ophthalmol Scand 85(5): 486-94 (2007)
2007 45	New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence. [17244204] Acta Ophthalmol Scand 85(1): 6-20 (2007)
2006 46	Age-related maculopathy and the impact of blue light hazard. [16445433] Acta Ophthalmol Scand 84(1): 4-15 (2006)
2003 47	Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss? [14510786] Acta Ophthalmol Scand 81(5): 427-9 (2003)
2003 48	Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapy. [12752045] Acta Ophthalmol Scand 81(2): 103-4 (2003)
2002 49	Age-related maculopathy: pathogenetic features and new treatment modalities. [11952478] Acta Ophthalmol Scand 80(2): 136-43 (2002)
2001 50	Ocular perfusion and age-related macular degeneration. [11284745] Acta Ophthalmol Scand 79(2): 108-15 (2001)
2010 51	Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database. [20628421] Can J Ophthalmol 45(3): 231-8 (2010)
2010 52	Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation. [20628420] Can J Ophthalmol 45(3): 223-30 (2010)
2010 53	Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab). [20130708] Can J Ophthalmol 45(1): 36-40 (2010)
2008 54	Age-related macular degeneration and low-vision rehabilitation: a systematic review. [18347620] Can J Ophthalmol 43(2): 180-7 (2008)
2005 55	Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. [15947805] Can J Ophthalmol 40(3): 352-68 (2005)
2005 56	Surgical management of age-related macular degeneration. [15947804] Can J Ophthalmol 40(3): 341-51 (2005)
2005 57	Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action. [15947803] Can J Ophthalmol 40(3): 332-40 (2005)
2005 58	Laser prophylaxis for age-related macular degeneration. [15947802] Can J Ophthalmol 40(3): 320-31 (2005)
2005 59	Preferred retinal loci and macular scotoma characteristics in patients with age-related macular degeneration. [15947800] Can J Ophthalmol 40(3): 303-12 (2005)
2005 60	Genetic aspects of age-related macular degeneration. [15947798] Can J Ophthalmol 40(3): 288-92 (2005)
2005 61	Age-related macular degeneration: economic burden and value-based medicine analysis. [15947797] Can J Ophthalmol 40(3): 277-87 (2005)
2005 62	Current concepts in macular degeneration: introduction. [15947796] Can J Ophthalmol 40(3): 254-5 (2005)
2008 63	[Update on the genetics of age-related macular degeneration]. [18772819] J Fr Ophtalmol 31(6 Pt 1): 630-7 (2008)
2007 64	[Toward prevention of age-related macular degeneration]. [17568337] J Fr Ophtalmol 30(5): 449-55 (2007)
2003 65	[Indocyanine green angiography in age-related macular degeneration]. [14586231] J Fr Ophtalmol 26(8): 854-63 (2003)
2007 66	Towards a rational approach to combination therapy for neovascular age-related macular degeneration. [17244655] Br J Ophthalmol 91(2): 130-1 (2007)
2006 67	Evolving European guidance on the medical management of neovascular age related macular degeneration. [16929063] Br J Ophthalmol 90(9): 1188-96 (2006)
2006 68	Which treatment is best for which AMD patient? [16424516] Br J Ophthalmol 90(2): 128-30 (2006)
2001 69	The role of choroidal haemodynamic abnormalities in the pathogenesis of age related macular degeneration. [11734506] Br J Ophthalmol 85(12): 1399-400 (2001)
2001 70	Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy. [11264143] Br J Ophthalmol 85(4): 483-95 (2001)
2000 71	Foveal translocation for exudative age related macular degeneration. [10729288] Br J Ophthalmol 84(4): 344-5 (2000)
2000 72	Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation. [10684831] Br J Ophthalmol 84(3): 239-43 (2000)
1999 73	Photocoagulation of subfoveal choroidal neovascular membranes in age related macular degeneration: the impact of the macular photocoagulation study in the United Kingdom and Republic of Ireland. [10502566] Br J Ophthalmol 83(10): 1103-4 (1999)
1999 74	Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration. [10413694] Br J Ophthalmol 83(8): 923-8 (1999)
1999 75	Macular pigment and age related macular degeneration. [10381676] Br J Ophthalmol 83(7): 867-77 (1999)
1998 76	Alternative therapies in exudative age related macular degeneration. [9930280] Br J Ophthalmol 82(12): 1441-3 (1998)
1996 77	Laser treatment of soft drusen in age-related maculopathy. [8664230] Br J Ophthalmol 80(1): 4 (1996)
1993 78	Choroidal neovascularisation in age-related macular disease. [7692955] Br J Ophthalmol 77(10): 614-5 (1993)
2003 79	The genetics of inherited macular dystrophies. [12960208] J Med Genet 40(9): 641-50 (2003)
2005 80	[Hereditary macular dystrophies]. [15767907] J Fr Ophtalmol 28(1): 113-24 (2005)
2003 81	[Macular dystrophies]. [13130265] J Fr Ophtalmol 26(7): 743-62 (2003)
1996 82	Molecular genetics of macular dystrophies. [8976733] Br J Ophthalmol 80(11): 1018-22 (1996)
2007 83	Treatment of exudative age-related macular degeneration: many factors to consider. [17659955] Am J Ophthalmol 144(2): 281-3 (2007)
2007 84	New treatments for neovascular acute macular degeneration. [17289688] BMJ 334(7588): 269-70 (2007)
2010 85	Age-related macular degeneration: why should stroke physicians care? [20150541] Stroke 41(4): 575-6 (2010)
2010 86	Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. [19797256] J Lipid Res 51(3): 451-67 (2010)
2010 87	Therapeutic targets in age-related macular disease. [20811159] J Clin Invest 120(9): 3033-41 (2010)
2007 88	Age-related macular degeneration and recent developments: new hope for old eyes? [17488857] Postgrad Med J 83(979): 301-7 (2007)
2010 89	Age-related macular degeneration. [20696800] CMAJ 182(16): 1759 (2010)
2006 90	Age-related macular degeneration (AMD): pathogenesis and therapy. [16845209] Pharmacol Rep 58(3): 353-63 (2006)
2006 91	The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration. [16865194] Ann Acad Med Singapore 35(6): 420-4 (2006)
2010 92	Age-related macular degeneration: genetic and environmental factors of disease. [21045241] Mol Interv 10(5): 271-81 (2010)
2010 93	Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. [20871825] Mediators Inflamm 2010(-): - (2010)
2006 94	Anecortave acetate in the treatment of age-related macular degeneration. [18046876] Clin Interv Aging 1(3): 237-46 (2006)
2008 95	Age-related macular degeneration and the aging eye. [18982917] Clin Interv Aging 3(3): 473-82 (2008)
2004 96	Treatment of age-related macular degeneration. [15056736] J R Soc Med 97(4): 166-9 (2004)
2010 97	Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration. [20238041] Adv Exp Med Biol 664(): 403-9 (2010)
2010 98	Animals as models of age-related macular degeneration: an imperfect measure of the truth. [20382825] Vet Pathol 47(3): 396-413 (2010)
2010 99	Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration. [20689785] Clin Ophthalmol 4(-): 703-7 (2010)
2010 100	Factors determining age-related macular degeneration: a current view. [20440081] Medicina (Kaunas) 46(2): 89-94 (2010)
2007 101	The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration. [17951901] Indian J Ophthalmol 55(6): 441-3 (2007)
2007 102	The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice. [17951902] Indian J Ophthalmol 55(6): 445-50 (2007)
2008 103	Recent advances in the treatment of age-related macular degeneration. [18482482] Br J Gen Pract 58(550): 309-10 (2008)
2006 104	Editorial: update on the modern management of wet age-related macular degeneration. [16767199] Can J Ophthalmol 41(2): 133-8 (2006)
2008 105	Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. [21221192] Core Evid 2(4): 273-94 (2008)
2002 106	Early detection and treatment of neovascular age-related macular degeneration. [12002198] J Am Board Fam Pract 15(2): 142-52 (2002)
2011 107	The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. [21127893] Graefes Arch Clin Exp Ophthalmol 249(2): 163-74 (2011)
2011 108	Prevention of age-related macular degeneration. [20862519] Int Ophthalmol 31(1): 73-82 (2011)
2005 109	Melanization and phagocytosis: implications for age related macular degeneration. [16030499] Mol Vis 11(-): 482-90 (2005)
2010 110	Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). [20206286] Prog Retin Eye Res 29(3): 169-90 (2010)
2009 111	Molecular pathology of age-related macular degeneration. [19026761] Prog Retin Eye Res 28(1): 1-18 (2009)
2011 112	A review of ranibizumab clinical trial data in exudative age-related macular degeneration and how to translate it into daily practice. [20938212] Ophthalmologica 225(2): 112-9 (2011)
2009 113	A comparison of macular translocation with patch graft in neovascular age-related macular degeneration. [19060287] Invest Ophthalmol Vis Sci 50(4): 1848-55 (2009)
2011 114	Age-related macular degeneration: genetic and clinical findings. [21175380] Clin Chem Lab Med 49(4): 601-16 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\AMD macular degeneration.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\AMD macular degeneration.php on line 92